NCT01914523

Brief Summary

Failure to successfully intubate the trachea and secure the airway remains a leading cause of morbidity and mortality, in the operative \[1-2\] and emergency settings. \[3-4\]. When the concept of endotracheal intubation was developed, 100 years ago the procedure was performed blindly. Shortly thereafter, laryngoscopes were invented, allowing for direct visualization of the larynx with a viewing angle of 15 degrees \[5\]. Insufficient laryngoscopic view constitutes the main reason for difficult intubations \[6\]. Video laryngoscopes provide an improved view of the glottis, as the camera is a few millimeters away from the glottis. The use of Glidescope \[7-8\] and AirTraq \[9\] laryngoscopes has superior glottis view and ease of tracheal intubation compared with the traditional Macintosh laryngoscope. Unfortunately, the use video laryngoscopes is associated with longer time to tracheal intubation compared with the traditional techniques which be explained with the variable learning curves of the practitioners. \[10\] The King Vision video laryngoscope® (King Systems Company, a division of Consort Medical, Indianapolis, Indiana, USA) is a relative newcomer to the video laryngoscopes of devices that claim to provide the "perfect view" for intubation via use of video and digital technology. The King Vision Video laryngoscope is a two piece design. It has a reusable monitor that attaches to disposable blades. Blades are made of high quality poly-carbonate plastic and house a complementary semi-conductor (CMOS) micro camera offers a 160 degree of view and LED light source. Up to best of the authors' knowledge, there is no current published or ongoing randomized controlled comparative study of the use of King Vision laryngoscope with traditional laryngoscope and other video laryngoscopes for endotracheal intubation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
86

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Sep 2013

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 28, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 2, 2013

Completed
1 month until next milestone

Study Start

First participant enrolled

September 1, 2013

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2015

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2015

Completed
Last Updated

May 14, 2015

Status Verified

May 1, 2015

Enrollment Period

1.5 years

First QC Date

July 28, 2013

Last Update Submit

May 12, 2015

Conditions

Keywords

LaryngoscopeMacintoshGlidescopeKing VisionAirTraqtracheal intubation

Outcome Measures

Primary Outcomes (1)

  • Time to tracheal intubation

    the time when the investigated laryngoscope passes the central incisors to the time when the tip of the tracheal tube passed through the glottis

    participants will be followed for the duration of tracheal intubation, an expected average of 60 seconds

Secondary Outcomes (6)

  • laryngoscopic view

    participants will be followed for the duration of laryngeal exposure, an expected average of 90 seconds

  • ease of intubation

    participants will be followed for the duration of tracheal intubation, an expected average of 60 seconds

  • number of intubation attempts

    participants will be followed for the duration of tracheal intubation, an expected average of 60 seconds

  • number of optimization maneuvers

    participants will be followed for the duration of tracheal intubation, an expected average of 60 seconds

  • duration of laryngoscopy

    during laryngoscopy

  • +1 more secondary outcomes

Study Arms (4)

Macintosh

PLACEBO COMPARATOR

tracheal intubation will be performed using a Macintosh

Device: Macintosh

King Vision

ACTIVE COMPARATOR

tracheal intubation will be performed using a King Vision

Device: King Vision

Glidescope

ACTIVE COMPARATOR

tracheal intubation will be performed using a Glidescope

Device: Glidescope

AirTraq

ACTIVE COMPARATOR

tracheal intubation will be performed using a AirTraq

Device: AirTraq

Interventions

MacintoshDEVICE

Laryngeal exposure and tracheal intubation using that device

Macintosh

Laryngeal exposure and tracheal intubation using that device

King Vision

Laryngeal exposure and tracheal intubation using that device

Glidescope
AirTraqDEVICE

Laryngeal exposure and tracheal intubation using that device

AirTraq

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of Anesthesiologists physical status class I-II
  • aged 18-65 years
  • scheduled for elective surgery
  • under general anesthesia

You may not qualify if:

  • Expected or known difficult airway
  • history of cervical spine injury
  • history of cervical spine surgery
  • previous throat surgery
  • previous oral surgery
  • gastro-esophageal reflux disease
  • pregnancy
  • need for rapid sequence induction
  • emergent surgery
  • body mass index higher than 35 kg/m2
  • Missing incisor teeth
  • Unstable hypertension
  • Unstable coronary artery disease
  • Asthma
  • Cerbrovascular disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Dammam University

Khobar, Eastern Province, 31259, Saudi Arabia

Location

King Fahd Hospital of the University

Khobar, Eastern Province, 31952, Saudi Arabia

Location

Study Officials

  • Abdulmohsen Al Ghamdi, MD

    Associate Professor/Chairman of Anesthesiology

    PRINCIPAL INVESTIGATOR
  • Mohamed R El Tahan, MD

    Associate Professor of Anesthesiology

    STUDY DIRECTOR
  • Alaa M Khidr, MD

    Assistant Professor of Anesthesiology

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 28, 2013

First Posted

August 2, 2013

Study Start

September 1, 2013

Primary Completion

March 1, 2015

Study Completion

April 1, 2015

Last Updated

May 14, 2015

Record last verified: 2015-05

Locations